See more : Simat Technologies Public Company Limited (SIMAT.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Walgreens Boots Alliance, Inc. (WBA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Walgreens Boots Alliance, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- SolarEdge Technologies, Inc. (SEDG) Income Statement Analysis – Financial Results
- Renren Inc. (RENN) Income Statement Analysis – Financial Results
- ECI Technology Holdings Limited (8013.HK) Income Statement Analysis – Financial Results
- Uni-Select Inc. (UNS.TO) Income Statement Analysis – Financial Results
- Drillcon AB (publ) (DRIL.ST) Income Statement Analysis – Financial Results
Walgreens Boots Alliance, Inc. (WBA)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.66B | 139.08B | 132.70B | 132.51B | 121.98B | 120.07B | 131.54B | 118.21B | 117.35B | 103.44B | 76.39B | 72.22B | 71.63B | 72.18B | 67.42B | 63.34B | 59.03B | 53.76B | 47.41B | 42.20B | 37.51B | 32.51B | 28.68B | 24.62B | 21.21B | 17.84B | 15.31B | 13.36B | 11.78B | 10.40B | 9.24B | 8.29B | 7.48B | 6.73B | 6.05B | 5.38B | 4.88B | 4.28B | 3.66B | 3.16B |
| Cost of Revenue | 121.13B | 112.01B | 104.44B | 104.44B | 95.91B | 91.92B | 100.75B | 89.05B | 87.48B | 76.59B | 54.82B | 51.10B | 51.29B | 51.69B | 48.44B | 45.72B | 42.39B | 38.52B | 34.24B | 30.41B | 27.31B | 23.71B | 21.08B | 18.05B | 15.24B | 12.77B | 10.95B | 9.52B | 8.37B | 7.35B | 6.50B | 5.85B | 5.29B | 4.74B | 4.29B | 3.78B | 3.41B | 2.95B | 2.51B | 2.16B |
| Gross Profit | 26.52B | 27.07B | 28.27B | 28.07B | 26.08B | 28.16B | 30.79B | 29.16B | 29.87B | 26.86B | 21.57B | 21.12B | 20.34B | 20.49B | 18.98B | 17.61B | 16.64B | 15.24B | 13.17B | 11.79B | 10.20B | 8.80B | 7.61B | 6.57B | 5.97B | 5.07B | 4.36B | 3.85B | 3.41B | 3.04B | 2.74B | 2.44B | 2.19B | 1.99B | 1.76B | 1.60B | 1.47B | 1.33B | 1.15B | 1.00B |
| Gross Profit Ratio | 17.96% | 19.46% | 21.30% | 21.18% | 21.38% | 23.45% | 23.41% | 24.67% | 25.46% | 25.96% | 28.23% | 29.24% | 28.40% | 28.39% | 28.15% | 27.81% | 28.19% | 28.35% | 27.78% | 27.93% | 27.19% | 27.07% | 26.52% | 26.70% | 28.16% | 28.42% | 28.46% | 28.77% | 28.96% | 29.29% | 29.66% | 29.42% | 29.29% | 29.53% | 29.13% | 29.65% | 30.18% | 31.16% | 31.54% | 31.75% |
| Research & Development | 0.00 | 371.00M | 307.00M | 284.00M | 300.00M | 260.00M | 254.00M | 245.00M | 238.00M | 178.00M | 127.00M | 105.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.62B | 24.70B | 24.13B | 23.03B | 22.30B | 22.60B | 23.97B | 23.05B | 22.83B | 21.18B | 17.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 694.00M | 775.00M | 862.00M | 772.00M | 532.00M | 582.00M | 665.00M | 571.00M | 598.00M | 491.00M | 265.00M | 286.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.11B | 25.48B | 24.99B | 23.80B | 22.84B | 23.18B | 24.64B | 23.62B | 23.43B | 21.67B | 17.69B | 17.47B | 16.88B | 16.56B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.52B | 3.84B | 3.33B | 2.97B | 2.66B | 2.39B | 2.16B | 1.93B | 1.74B | 1.58B | 1.41B | 1.28B | 1.19B | 1.07B | 914.00M | 791.70M |
| Other Expenses | 0.00 | 8.10B | 1.58B | 1.64B | 1.96B | -50.00M | -389.00M | -185.00M | 210.00M | 344.00M | -443.00M | 0.00 | 0.00 | -434.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| Operating Expenses | 40.60B | 33.95B | 26.88B | 25.73B | 25.10B | 23.39B | 24.50B | 23.68B | 23.87B | 22.19B | 17.38B | 16.98B | 16.88B | 16.13B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.75B | 4.05B | 3.52B | 3.14B | 2.81B | 2.52B | 2.28B | 2.03B | 1.83B | 1.67B | 1.48B | 1.34B | 1.25B | 1.12B | 957.80M | 826.10M |
| Cost & Expenses | 161.73B | 145.96B | 131.32B | 130.17B | 121.00B | 115.31B | 125.25B | 112.73B | 111.35B | 98.78B | 72.20B | 68.08B | 68.17B | 67.82B | 63.96B | 60.09B | 55.59B | 50.61B | 44.71B | 39.78B | 35.37B | 30.66B | 27.06B | 23.22B | 19.98B | 16.82B | 14.47B | 12.66B | 11.17B | 9.88B | 8.78B | 7.89B | 7.12B | 6.41B | 5.76B | 5.13B | 4.66B | 4.07B | 3.46B | 2.98B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.00M | 0.00 | 0.00 | 0.00 | 0.00 | 134.00M | 0.00 | 95.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 482.00M | 580.00M | 396.00M | 491.00M | 613.00M | 650.00M | 616.00M | 693.00M | 596.00M | 605.00M | 156.00M | 165.00M | 88.00M | 71.00M | 85.00M | 83.00M | 11.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.46B | 1.89B | 1.68B | 1.69B | 1.63B | 1.78B | 1.52B | 1.41B | 1.48B | 1.56B | 1.21B | 1.18B | 1.17B | 1.09B | 1.03B | 975.00M | 840.00M | 675.90M | 572.20M | 482.10M | 403.10M | 346.10M | 307.30M | 269.20M | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| EBITDA | -11.28B | 3.48B | 4.96B | 5.96B | 2.84B | 6.75B | 7.67B | 6.95B | 7.93B | 6.75B | 5.08B | 5.34B | 4.63B | 5.45B | 4.49B | 4.22B | 4.28B | 3.83B | 3.27B | 2.91B | 2.55B | 2.21B | 1.93B | 1.67B | 1.45B | 1.23B | 1.02B | 872.60M | 751.40M | 651.60M | 573.80M | 510.90M | 450.60M | 405.50M | 354.60M | 317.30M | 283.60M | 264.40M | 240.40M | 212.20M |
| EBITDA Ratio | -7.64% | -1.86% | 4.80% | 4.12% | 2.37% | 5.31% | 6.36% | 6.09% | 6.36% | 7.40% | 6.58% | 7.37% | 6.46% | 7.55% | 6.66% | 6.67% | 7.25% | 7.12% | 6.91% | 6.89% | 6.74% | 6.66% | 6.71% | 6.68% | 6.70% | 6.87% | 6.45% | 6.48% | 6.34% | 6.22% | 6.15% | 6.16% | 5.89% | 5.89% | 5.61% | 5.73% | 5.72% | 6.15% | 6.51% | 6.65% |
| Operating Income | -14.08B | -6.88B | 1.39B | 2.34B | 982.00M | 4.77B | 6.29B | 5.48B | 6.00B | 4.67B | 4.19B | 3.65B | 3.46B | 4.37B | 3.46B | 3.25B | 3.44B | 3.15B | 2.70B | 2.42B | 2.14B | 1.85B | 1.62B | 1.40B | 1.22B | 1.02B | 835.00M | 708.00M | 604.10M | 520.10M | 455.70M | 406.20M | 358.50M | 321.20M | 284.20M | 253.50M | 224.20M | 210.70M | 196.60M | 177.80M |
| Operating Income Ratio | -9.53% | -4.95% | 1.05% | 1.77% | 0.81% | 3.97% | 4.78% | 4.64% | 5.11% | 4.51% | 5.49% | 5.05% | 4.84% | 6.05% | 5.13% | 5.13% | 5.83% | 5.86% | 5.70% | 5.74% | 5.71% | 5.69% | 5.66% | 5.68% | 5.77% | 5.69% | 5.46% | 5.30% | 5.13% | 5.00% | 4.93% | 4.90% | 4.80% | 4.77% | 4.70% | 4.71% | 4.59% | 4.92% | 5.37% | 5.62% |
| Total Other Income/Expenses | -126.00M | 1.46B | 2.65B | 280.00M | -505.00M | -399.00M | -260.00M | -623.00M | -813.00M | 667.00M | -637.00M | -45.00M | -88.00M | -71.00M | -85.00M | -83.00M | -11.00M | 28.80M | 52.60M | -11.30M | 17.00M | 23.40M | 13.10M | 24.40M | 39.20M | 11.90M | 42.10M | 4.60M | 2.80M | 3.70M | 2.70M | -6.50M | -5.50M | -9.20M | -3.30M | -9.70M | -15.20M | -16.60M | -9.00M | -4.10M |
| Income Before Tax | -14.20B | -5.39B | 4.04B | 2.62B | 477.00M | 4.37B | 6.03B | 4.86B | 5.19B | 5.34B | 3.56B | 4.05B | 3.38B | 4.29B | 3.37B | 3.16B | 3.43B | 3.19B | 2.75B | 2.46B | 2.18B | 1.89B | 1.64B | 1.42B | 1.26B | 1.03B | 877.00M | 712.00M | 606.90M | 523.80M | 458.40M | 399.70M | 353.00M | 312.00M | 280.90M | 243.80M | 209.00M | 194.10M | 187.60M | 173.70M |
| Income Before Tax Ratio | -9.62% | -3.87% | 3.04% | 1.98% | 0.39% | 3.64% | 4.58% | 4.11% | 4.42% | 5.16% | 4.66% | 5.60% | 4.71% | 5.95% | 5.00% | 5.00% | 5.81% | 5.93% | 5.81% | 5.82% | 5.80% | 5.81% | 5.71% | 5.78% | 5.96% | 5.76% | 5.73% | 5.33% | 5.15% | 5.04% | 4.96% | 4.82% | 4.72% | 4.63% | 4.64% | 4.53% | 4.28% | 4.53% | 5.12% | 5.49% |
| Income Tax Expense | 1.25B | 1.86B | 30.00M | 667.00M | 339.00M | 577.00M | 998.00M | 760.00M | 997.00M | 1.06B | 1.53B | 1.50B | 1.25B | 1.58B | 1.28B | 1.16B | 1.27B | 1.15B | 1.00B | 896.10M | 816.10M | 713.00M | 618.10M | 537.10M | 486.40M | 403.20M | 340.00M | 276.00M | 235.20M | 203.00M | 176.50M | 154.40M | 132.40M | 117.00M | 106.30M | 89.60M | 79.90M | 90.60M | 84.50M | 79.50M |
| Net Income | -8.64B | -3.08B | 4.34B | 2.54B | 456.00M | 3.98B | 5.02B | 4.08B | 4.17B | 4.22B | 1.93B | 2.55B | 2.13B | 2.71B | 2.09B | 2.01B | 2.16B | 2.04B | 1.75B | 1.56B | 1.36B | 1.18B | 1.02B | 885.60M | 776.90M | 624.10M | 511.00M | 436.00M | 371.70M | 320.80M | 281.90M | 221.70M | 220.60M | 195.00M | 174.60M | 154.20M | 129.10M | 103.50M | 103.10M | 94.20M |
| Net Income Ratio | -5.85% | -2.21% | 3.27% | 1.92% | 0.37% | 3.32% | 3.82% | 3.45% | 3.56% | 4.08% | 2.53% | 3.53% | 2.97% | 3.76% | 3.10% | 3.17% | 3.65% | 3.80% | 3.69% | 3.70% | 3.63% | 3.62% | 3.55% | 3.60% | 3.66% | 3.50% | 3.34% | 3.26% | 3.16% | 3.09% | 3.05% | 2.67% | 2.95% | 2.90% | 2.89% | 2.87% | 2.64% | 2.42% | 2.82% | 2.98% |
| EPS | -10.01 | -3.57 | 5.02 | 2.31 | 0.20 | 4.14 | 5.07 | 3.80 | 3.85 | 4.05 | 2.03 | 2.69 | 2.43 | 2.97 | 2.13 | 2.03 | 2.18 | 2.04 | 1.73 | 1.53 | 1.32 | 1.14 | 1.00 | 0.87 | 0.77 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -10.01 | -3.57 | 5.01 | 2.30 | 0.20 | 4.13 | 5.05 | 3.78 | 3.82 | 4.00 | 2.00 | 2.67 | 2.42 | 2.94 | 2.12 | 2.02 | 2.17 | 2.03 | 1.72 | 1.52 | 1.31 | 1.13 | 0.99 | 0.86 | 0.76 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 863.10M | 863.20M | 864.40M | 864.80M | 879.40M | 921.50M | 991.00M | 1.07B | 1.08B | 1.04B | 953.10M | 946.00M | 874.70M | 915.10M | 981.70M | 990.00M | 990.61M | 998.63M | 1.01B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.01B | 1.00B | 1.98B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
| Weighted Avg Shares Out (Dil) | 863.10M | 863.20M | 865.90M | 866.40M | 880.30M | 923.50M | 995.00M | 1.08B | 1.09B | 1.05B | 965.20M | 955.20M | 880.10M | 924.50M | 987.90M | 991.30M | 995.54M | 1.01B | 1.02B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.02B | 1.01B | 2.01B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
Walgreens Q4 Earnings Preview: Don't Catch The Falling Knife
Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q4 2024 results on Tuesday, October 15 (Walgreens' fiscal ends in August). We expect the company to post mixed results, with revenue of $34.9 billion and earnings of $0.38 per share,...
Walgreens Stock Desperately Needs a Post-Earnings Pop
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) are up 0.8% to trade at $8.99 this afternoon, brushing off this morning's price-target cut to $11 from $13 at Deutsche Bank.
Unlocking Q4 Potential of Walgreens (WBA): Exploring Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Walgreens (WBA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended August 2024.
Walgreens Boots Alliance vs. Altria Group: What's the Better Dividend Stock to Own?
These stocks offer a lot of dividend income, but are they worth the risk?
Buy 4 October Dividend Aristocrats & Watch 10
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.5%-20.13% topped-by...
Is Walgreens Boots Alliance Inc (WBA) Set to Underperform? Analyzing the Factors Limiting Growth
Long-established in the Healthcare Providers & Services industry, Walgreens Boots Alliance Inc (WBA, Financial) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.17%, juxtaposed with a three-month change of -13.27%.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Ultra-High-Yield Dividend Stocks Are Near 52-Week Lows. Is It Time to Buy the Dips?
With yields of 8% or better at recent prices, these dividend payers are hard to ignore.
Walgreens Boots Alliance (WBA) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $8.88, denoting a +1.83% change from the preceding trading day.
Assessing WBA Before Q4 Earnings: How Should You Play the Stock?
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
Source: https://incomestatements.info
Category: Stock Reports